This white paper outlines how global pharmaceutical companies can ensure local pharmacovigilance compliance. Local affiliates face varying regulations, language requirements and data‑privacy laws, necessitating local expertise, translation support and global oversight. The paper highlights roadblocks such as cost pressures and inconsistent processes, and recommends frameworks and technologies—like AI translation, automated redaction and organized workflows—to harmonize local and global PV systems. Robust training, PV agreements and quality management help maintain compliance and efficiency while mitigating risk.

Join for free to read